TCT-269 Optical Coherence Tomography evaluation of Very Early eNdothelialization after Dual Therapy Drug-eluting Stent with EPC CaptURE (OCT-VENTURE)

The Combo drug-eluting stent (OrbusNeich Medical, Inc, Fort Lauderdale, FL) has an abluminal sirolimus-eluting bioabsorbable polymer and a luminal CD34+ antibody designed to capture endothelial progenitor cells to promote early re-endothelialization. This is the first prospective study to evaluate